TrialThe Lancet. Infectious diseases2022

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.

Muhammed O Afolabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.